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Hepatocyte-like cells differentiated from human iPS cells (human iPS-HLCs) are expected to be utilized in
drug development and research. However, recent hepatic characterization of human iPS-HLCs showed
that these cells resemble fetal hepatocytes rather than adult hepatocytes. Therefore, in this study, we
aimed to develop a method to enhance the hepatic function of human iPS-HLCs. Because the gene
expression levels of the hepatic transcription factors (activating transcription factor 5 (ATF5), CCAAT/
enhancer-binding protein alpha (c/EBPa), and prospero homeobox protein 1 (PROX1)) in adult liver
were signiﬁcantly higher than those in human iPS-HLCs and fetal liver, we expected that the hepatic
functions of human iPS-HLCs could be enhanced by adenovirus (Ad) vector-mediated ATF5, c/EBPa, and
PROX1 transduction. The gene expression levels of cytochrome P450 (CYP) 2C9, 2E1, alpha-1 antitrypsin,
transthyretin, Naþ/taurocholate cotransporting polypeptide, and uridine diphosphate glucuronosyl trans-
ferase 1A1 and protein expression levels of CYP2C9 and CYP2E1 were upregulated by ATF5, c/EBPa, and
PROX1 transduction. These results suggest that the hepatic functions of the human iPS-HLCs could be
enhanced by ATF5, c/EBPa, and PROX1 transduction. Our ﬁndings would be useful for the hepatic
maturation of human iPS-HLCs.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).luripotent stem cells-derived
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Inc. This is an open access article u1. Introduction
The liver is an important organ in term of the absorption, dis-
tribution, metabolism, and excretion of drugs. Therefore, to develop
safe and effective drugs, primary human hepatocytes (PHHs) are
widely used in the early stage of drug development. However,
alternative hepatocyte resources for drug screening are required
because PHHs are costly and not abundantly available. Hepatocyte-
like cells (HLCs) that are generated from human induced pluripo-
tent stem (iPS) cells are expected to be used in drug screening in
place of PHHs. We previously reported that the stage-speciﬁc
transient transduction of hepatic transcription factors mediated
by adenovirus (Ad) vector was useful for promoting hepatic dif-
ferentiation [1e4]. However, the drug metabolism capacity of hu-
man iPS-HLCs is still lower than that of PHHs [4]. In addition, Baxternder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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that the human iPS-HLCs better mimic fetal hepatocytes rather
than adult hepatocytes [5]. Therefore, it is necessary to promote the
hepatic maturation of human iPS-HLCs.
Recently, Du et al. showed that metabolically functioning hu-
man induced hepatocytes (hiHeps) can be converted from ﬁbro-
blasts by overexpressing the hepatic fate conversion factors
hepatocyte nuclear factor 1 alpha, 4 alpha, and 6 (HNF1a, HNF4a,
HNF6, respectively) [6]. In addition, they demonstrated that hiHeps
could be further maturated by overexpressing activating tran-
scription factor 5 (ATF5), CCAAT/enhancer-binding protein alpha (c/
EBPa), and prospero homeobox protein 1 (PROX1). Consistently, all
the hepatic transcription factors (ATF5, c/EBPa, and PROX1) are
known to play an important role in the maturation of hepatocytes
and maintenance of hepatic function. Speciﬁcally, it is known that
the level of cytochrome P450 (CYP) 2B6 expression in hepatocytes
is regulated by ATF5, and also cooperatively regulated with the
hepatic nuclear receptor, constitutive androstane receptor (CAR)
[7]. The hepatic functions, such as albumin secretion and urea
production, are positively regulated by c/EBPa [8]. It has also been
reported that PROX1 plays a key role in themetabolic maturation of
hepatocytes, as well as FOXA2 [9]. Considering these results
together, we expected that the hepatic functions of human iPS-
HLCs could be improved by the transduction of three transcrip-
tion factors, ATF5, c/EBPa, and PROX1.
In this study, we attempt to produce matured human iPS-HLCs
by Ad vector-mediated ATF5, c/EBPa, and PROX1 (3TFs) trans-
duction. To investigate whether the hepatic functions were
enhanced, we analyzed the expression of hepatocytemarkers in the
Ad-3TFs-transduced human iPS-HLCs. Moreover, the protein
expression levels of CYP2C9, CYP2E1, and a-1 antitrypsin (aAT)
were examined by western blotting and immunoﬂuorescent
staining.
2. Materials and methods
2.1. Human iPS cells
Human iPS cells generated from the human embryonic lung
ﬁbroblast cell line MCR5 were provided from the JCRB Cell Bank
(Dotcom, JCRB Number: JCRB1327). Human iPS cells were main-
tained on a feeder layer of mitomycin C-treated mouse embryonic
ﬁbroblasts (Millipore) with ReproStem (ReproCELL) supplemented
with 10 ng/ml ﬁbroblast growth factor (FGF) 2 (KATAYAMA Kogyo
Kagaku).
2.2. Hepatocyte differentiation
Before the initiation of hepatocyte differentiation, human iPS
cells were dissociated into clumps by using dispase (Roche Di-
agnostics) and plated onto BD Matrigel Basement Membrane Ma-
trix Growth Factor Reduced (Becton, Dickinson and Company).
These cells were cultured in the mouse embryo ﬁbroblasts-
conditioned medium for 3e4 days. The differentiation protocol
for the induction of deﬁnitive endoderm cells, hepatoblast-like
cells, and human iPS-HLCs was based on our previous reports
with some modiﬁcations [10]. Brieﬂy, in the deﬁnitive endoderm
differentiation, human iPS cells were cultured with the L-Wnt3A-
expressing cell (CRL2647; ATCC)-conditioned RPMI1640 medium
(Sigma) containing 100 ng/mL Activin A (R&D Systems), 1% Gluta-
MAX (Invitrogen), 0.2% fetal bovine serum (FBS), and 1  B27
Supplement Minus Vitamin A (Invitrogen) for 4 days. For the in-
duction of hepatoblasts, the deﬁnitive endoderm cells were
cultured with RPMI1640 medium containing 30 ng/mL bone
morphogenetic protein 4 (BMP4) (R&D Systems) and 20 ng/mLFGF4 (R&D Systems), 1% GlutaMAX, and 1 B27 SupplementMinus
Vitamin A for 5 days. To perform the hepatocyte differentiation, the
hepatoblast-like cells were cultured with RPMI1640 medium con-
taining 20 ng/mL hepatocyte growth factor (HGF) (R&D Systems),
1% GlutaMAX, and 1 B27 Supplement Minus Vitamin A for 5 days.
Finally, the cells were cultured with hepatic maturation medium
(hepatic maturation medium consists of Hepatocyte Culture Me-
dium (HCM; Lonza, without epidermal growth factor (EGF)) con-
taining 20 ng/mL oncostatin M (OsM) and 3% GlutaMAX) for 11
days. To promote hepatic maturation, human iPS-HLCs were
transduced with 1000 VP/cell of Ad-ATF5, Ad-c/EBPa, and Ad-
PROX1 (total 3000 VP/cell) for 1.5 h on day 25 and were cultured
with hepatic maturation medium for 5 days.
2.3. Ad vector
Ad vectors were constructed by an improved in vitro ligation
method [11,12]. The human ATF5 and PROX1 gene (accession
number NM_ 001193646 and NM_ 001270616, respectively) were
ampliﬁed by PCR using primers: ATF5 Fwd 50- TGtcta-
gaCCACCATGTCACTCCTGGCGACCCTG -30 and ATF5 Rev 50-
AAgcggccgcCTAGCAGCTACGGGTCCTCTG -3’; PROX1 Fwd 50- AGtc-
tagaCCACCATGCCTGACCATGACAGCAC -30 and PROX1 Rev 50-
TAgcggccgcCTACTCATGAAGCAGCTCTTG -3’. The human ATF5 and
PROX1 gene was inserted into pHMEF5 [13], which contains the
human elongation factor-1a (EF-1a) promoter, resulting in pHMEF-
ATF5 and -PROX1, respectively. The pHMEF-ATF5 and -PROX1 was
digested with I-CeuI/PI-SceI and ligated into I-CeuI/PI-SceI-digested
pAdHM41-K7 [14], resulting in pAd-ATF5 and pAd-PROX1, respec-
tively. The human EF-1a promoter-driven LacZ- and c/EBPa-
expressing Ad vectors (Ad-LacZ and Ad-c/EBPa, respectively) were
constructed previously [15,16]. Ad-LacZ, Ad-ATF5, Ad-c/EBPa, and
Ad-PROX1, each of which contains a stretch of lysine residue (K7)
peptides in the C-terminal region of the ﬁber knob for more efﬁ-
cient transduction of human iPS cells, deﬁnitive endoderm cells,
and hepatoblast-like cells were used in this study. The vector par-
ticle (VP) titer was determined by using a spectrophotometric
method [17].
2.4. Real-time RT-PCR
Total RNA was isolated from human iPS cells and their de-
rivatives using ISOGENE (NIPPON GENE). cDNA was synthesized
using 500 ng of total RNA with a Superscript VILO cDNA synthesis
kit (Invitrogen). Real-time RT-PCR was performed with SYBR Green
PCR Master Mix (Applied Biosystems) using a StepOnePlus real-
time PCR system (Applied Biosystems). Relative quantiﬁcation
was performed against a standard curve and the values were
normalized against the input determined for the housekeeping
gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The
primer sequences used in this study are described in Table S1. Fetal
liver and Adult liver total RNA were purchased from Clontech and
BioChain, respectively.
2.5. Western blotting
The human iPS cell-derivatives were homogenized with RIPA
Lysis and Extraction Buffer (Thermo Fisher Scientiﬁc) containing a
protease inhibitor mixture (Sigma). After being frozen and thawed,
the homogenates were centrifuged at 15,000 g at 4 C for 10 min,
and the supernatants were collected. The lysates were subjected to
SDS-PAGE on 7.5% polyacrylamide gel, and then transferred onto
polyvinylidene ﬂuoride membranes (Millipore). After the reaction
was blocked with 1% skim milk in TBS containing 0.1% Tween 20
(Sigma) at room temperature for 1 h, the membranes were
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4 C overnight, followed by reaction with horseradish peroxidase-
conjugated anti-mouse or anti-goat IgG antibodies at room tem-
perature for 1 h. All the antibodies are listed in Table S2. The band
was visualized by ECL Plus Western blotting detection reagents (GE
Healthcare) and the signals were read using an LAS-4000 imaging
system (Fuji Film).2.6. Immunohistochemistry
To perform the immunohistochemistry, the cells were ﬁxed
with 4% paraformaldehyde (PFA, Wako) in PBS for 20 min. After
incubation with 0.1% Triton X-100 (Sigma) in PBS for 10 min, the
cells were blocked with PBS containing 2% FBS and 2% bovine
serum albumin (BSA) for 50 min, the cells were incubated with a
primary antibody at 4 C overnight, and ﬁnally, incubated with a
secondary antibody at room temperature for 1 h. All the antibodies
are listed in Table S3.2.7. X-gal staining
Human iPS-HLCs were transduced with Ad-LacZ at 3000 VP/cell
for 1.5 h. After culturing for 2 days, 5-bromo-4-chloro-3-indolyl b-D-
galactopyranoside (X-Gal) (NIPPON GENE) staining was performed
as described previously [13].3. Results
3.1. Expression analysis of ATF5, c/EBPa, and PROX1 among human
iPS-HLCs, fetal liver, and adult liver
To generate the human iPS-HLCs, hepatic differentiation was
performed according to the protocol shown in Fig. 1A. Because the
expression levels of ATF5, c/EBPa and PROX1 (three transcription
factors: 3TFs) in the human iPS-HLCs and fetal liver were lower
than those in adult liver (Fig. 1B), we expected that the hepatic
functions of the human iPS-HLCs would be enhanced by 3TFs
overexpression. To overexpress 3TFs in the human iPS-HLCs, we
produced an ATF5-expressing Ad vector (Ad-ATF5), a c/EBPa-
expressing Ad vector (Ad-c/EBPa), and a PROX1-expressing Ad
vector (Ad-PROX1). First, we prepared LacZ-expressing Ad vector
(Ad-LacZ) to examine the transduction efﬁciency in the human iPS-
HLCs. The human iPS-HLCs were transduced with Ad-LacZ at 3000
VP/cell, and LacZ expression in the cells was examined by X-Gal
staining. The Ad-LacZ-transduced human iPS-HLCs homogeneously
expressed LacZ (Fig. 1C). This result indicated that the transgene
could be efﬁciently overexpressed in the human iPS-HLCs by using
our Ad vectors. Next, the human iPS-HLCs were transduced with
Ad-ATF5, Ad-c/EBPa, and Ad-PROX1 at 1000 VP/cell per each Ad
vector. We conﬁrmed that 3TFs overexpression was successfully
performed by using Ad-3TFs (Fig. 1D).Fig. 1. Efﬁcient Ad vector-mediated hepatic gene transfer into the human iPS cell-derived h
into hepatocyte-like cells (human iPS-HLCs) via deﬁnitive endoderm cells and hepatoblast-li
1000 VP/cell of three transcription factors (3TFs; ATF5, c/EBPa, and PROX1)-expressing Ad
hepatic differentiation procedure are described in the Materials and Methods section. (B) Th
adult liver were examined by real-time RT-PCR. On the y axis, the gene expression level in ad
according to the protocol described in Fig. 1A, and then transduced with 3000 VP/cell of Ad-
(D) The gene expression levels of ATF5, c/EBPa, and PROX1 in Ad-LacZ- or Ad-3TFs-transduce
Ad-LacZ-transduced cells were taken as 1.0. All data are represented as means ± SD (n ¼ 33.2. Hepatic maturation of the human iPS-HLCs by transduction of
ATF5, c/EBPa, and PROX1
To examinewhether the human iPS-HLCs could bematurated by
ATF5, c/EBPa, and PROX1 transduction, the human iPS-HLCs were
transduced with Ad-ATF5, Ad-c/EBPa, and Ad-PROX1 (Ad-3TFs) on
day 25 of differentiation. At 5 days after the transduction, the gene
expression levels of hepatocyte-related markers, including major
drug metabolizing enzymes, in the human iPS-HLCs were exam-
ined by real-time RT-PCR. The gene expression levels of CYP2C9,
CYP2E1, aAT, transthyretin (TTR), Naþ/taurocholate cotransporting
polypeptide (NTCP), and uridine diphosphate glucuronosyl transferase
1A1 (UGT1A1) in the Ad-3TFs-transduced human iPS-HLCs were
signiﬁcantly higher than those in the Ad-LacZ-transduced human
iPS-HLCs (Fig. 2A). The protein expression levels of CYP2C9 and
CYP2E1 were also upregulated by Ad-3TFs transduction (Fig. 2B).
Moreover, immunoﬂuorescent staining of aAT showed that its
expression level in the human iPS-HLCs was enhanced by 3TFs
transduction (Fig. 2C). Interestingly, the gene expression levels of
forkhead box protein A2 (FOXA2), HNF1a, HNF4a, aryl hydrocarbon
receptor (AhR), constitutive androstane receptor (CAR), peroxisome
proliferator-activated receptor alpha (PPARa and liver X receptor
(LXR) were also increased (Fig. 3). These results suggest that the
hepatic functions of the human iPS-HLCs were enhanced by 3TFs
transduction.
4. Discussion
In this study, the human iPS-HLCs were transduced with Ad-
3TFs to enhance the hepatic functions of these cells. As shown in
Fig. 2, the gene expression levels of hepatic markers (CYP2C9, 2E1,
aAT, TTR, NTCP, and UGT1A1), the protein expression levels of he-
patic markers (CYP2C9, 2E1, and aAT), and the gene expression
levels of hepatic transcription factors and nuclear receptors (FOXA2,
HNF1a, HNF4a, GATA4, AhR, CAR, PPARa, and LXR) were upregulated
by Ad-3TFs transduction.
We consider that the hepatic functions of human iPS-HLCs could
be successfully enhanced by 3TFs, because the expression of many
hepatocyte transcription factors and nuclear receptors that play
crucial roles in hepatocyte differentiation and maturation were
signiﬁcantly upregulated (Fig. 3). Speciﬁcally, the gene expression
levels of HNF4a, FOXA2, HNF1a, and LXRwere increased by Ad-3TFs
transduction. It has been shown that the maturation of hepatocytes
from hepatoblasts [3], direct reprogramming of ﬁbroblasts into
hepatocytes [6,18], and transdifferentiation into hepatocytes [19]
could be promote by HNF4a overexpression. It is also known that
the combination of two transcription factors, FOXA2 and HNF1a,
promoted efﬁcient hepatic differentiation from human iPS cells [4].
Finally, the transcription factor LXR was shown to contribute to the
differentiation of functional hepatocytes from HepaRG cells [20].
Taken together, these results suggest that the Ad-3TFs transduction
could enhance the hepatic functions of human iPS-HLCs through
upregulation of HNF4a, FOXA2, HNF1a, and LXR expression levels.
We have previously reported that the hepatocyte differentiation
of human iPS cells could be promoted by overexpression of hepaticepatocyte-like cells. (A) The procedure for differentiation of human iPS cells (Dotcom)
ke cells is presented schematically. The human iPS-HLCs (day 25) were transduced with
vector (Ad-3TFs; total 3000 VP/cell) for 1.5 h, and cultured until day 30. Details of the
e gene expression levels of ATF5, c/EBPa, and PROX1 in human iPS-HLCs, fetal liver, and
ult liver was taken as 1.0. (C) Human iPS cells were differentiated into human iPS-HLCs
LacZ for 1.5 h. On day 27, X-gal staining was performed. The scale bars represent 50 mm.
d cells were examined by real-time RT-PCR. On the y axis, the gene expression levels in
).
Fig. 2. Hepatic maturation of human iPS cell-derived hepatocyte-like cells by ATF5, c/EBPa, and PROX1 transduction. Human iPS cells (Dotcom) were differentiated into human iPS-
HLCs as described in Fig. 1A. (A) The gene expression levels of CYP2C9, 2C19, 2E1, 3A4, aAT, TTR, NTCP, and UGT1A1 in Ad-LacZ- or Ad-TFs-transduced cells were examined by real-
time RT-PCR. On the y axis, the expression levels in Ad-LacZ-transduced cells were taken as 100. (B) The protein expression levels of CYP2C9 and CYP2E1 in Ad-LacZ- or Ad-TFs-
transduced cells were examined by western blotting. (C) Ad-LacZ- or Ad-TFs-transduced cells were subjected to immunostaining with anti-aAT (green) antibodies. Nuclei were
counterstained with DAPI (blue). The scale bars represent 50 mm. All data are represented as means ± SD (n ¼ 3).
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transcription factors that are known to be involved in fetal liver
development. In the present study, our focus was on hepaticFig. 3. Gene expression analysis of hepatic transcription factors and nuclear receptors
in the human iPS cell-derived hepatocyte-like cells. Human iPS cells (Dotcom) were
differentiated into human iPS-HLCs as described in Fig. 1A. The gene expression levels
of FOXA2, HNF1a, HNF4a, GATA4, AhR, CAR, PPARa and LXR in Ad-LacZ- or Ad-TFs-
transduced cells were examined by real-time RT-PCR. On the y axis, the expression
levels in Ad-LacZ-transduced cells were taken as 100. All data are represented as
means ± SD (n ¼ 3).transcription factors that play an important role in postnatal liver
development, and these genes were transduced into the human
iPS-HLCs (Fig. 1B). Because it is known that hepatic functions are
still rapidly enhanced during the postnatal period [21], further
maturated human iPS-HLCs might be possible to generate by
establishing a differentiation protocol which mimic the environ-
ment of postnatal liver.
In summary, we succeeded in generating more matured human
iPS-HLCs by overexpressing 3TFs. The expression levels of hepatic
markers, including drug metabolism enzymes and hepatic trans-
porters, were upregulated by Ad-3TFs transduction. We believe
that these more matured human iPS-HLCs would be useful tools for
drug screening and evaluation of drug response.Acknowledgments
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